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Recently, patients with urologic malignancies are treated with robot-assisted sur-
gery and the expanded role of robot-assisted surgery includes even those patients 
with two concomitant primary urologic malignancies. In an effort to further reduce 
port site-related morbidity, robot-assisted laparoendoscopic single-site surgery 
(RLESS) has been developed. Therefore, we present herein our early experience 
and feasibility of simultaneous RLESS partial nephrectomy and standard robotro-
bot-assisted laparoendoscopic radical prostatectomy (RALP) on 3 patients with 
synchronous renal masses and prostate cancer.
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INTRODUCTION
In the era of prostate specific antigen (PSA) screening, the incidence of prostate 
cancer has been increasing in the past decade. Similar to prostate cancer, renal 
masses are also detected more and more on routine health examination with wide 
use of abdominal ultrasonography and computed tomography (CT) scan.1-5
With a technological advancement, patients with urologic malignancies have 
been treated with robot-assisted surgery, and the expanded role of robot-assisted 
surgery includes even those patients with two concomitant primary urologic ma-
lignancies.1,2 In addition, with an effort to reduce the invasiveness, robot-assisted 
laparoendoscopic single-site surgery (RLESS) has been developed.6
Therefore, we report our early experience and feasibility of simultaneous RLESS 
partial nephrectomy (RLESS PN) and standard robotrobot-assisted laparoendo-
scopic radical prostatectomy (RALP).
CASE REPORT
From August 2009 to July 2010, we performed simultaneous RLESS PN and stan-
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and androgen deprivation therapy before surgery. 
Position, port placement, and surgical techniques (Fig. 1). 
The patient was placed in conventional flanked kidney po-
sition with the ipsilateral side elevated during RLESS PN 
or Trendelenburg position during RALP. In initial cases (1 
and 2), we performed RALP first and then 4 cm long inci-
sion was made for prostate specimen removal and RLESS 
PN. In the last case (3), we carried out RLESS PN first. 
Finishing one procedure, we re-prepared the patient proper-
ly according to the next procedure. Port placement strategy 
and surgical techniques of RLESS PN and RALP were 
have been described previously.3,6 
Results
The characteristics of the 3 patients are listed in Table 1. 
The median age of the patients was 61 years, and the medi-
an body mass index was 24 kg/m2. The median renal tumor 
size was 2.7 cm, and preoperative creatinine levels of all 
patients were normal. For prostate cancer, the median pre-
operative PSA was 7.42 ng/mL and Gleason scores were 
higher than 7 in all patients. These prostate cancers were 
clinically advanced, and salvage RALP was performed in 
one patient. The median operation time was 342 minutes, 
and the median console time was 200 minutes. The median 
dard RALP on 3 patients with synchronous renal masses 
and prostate cancer. The renal masses were found inciden-
tally during contrast enhanced CT as preoperative workup 
for prostate cancer. One patient underwent a radiotherapy 
Table 1. Preoperative Patients Characteristics
Age BMI Cormorbidity
Prostate Kidney
PSA (ng/mL) Gleason score Clinical stage
Creatinine 
(mg/dL)
Tumor size 
(cm)
1 72 28 -     0.30 8 (5+3) Salvage 1.1 5.3
2 55 24 HTN, DM     7.42 8 (4+4) T3a 1.0 2.7
3 61 23 HTN   61.21 7 (3+4) T3b 1.0 1.6
BMI, body mass index; PSA, prostate specific antigen; HTN, hypertension; DM, diabetes mellitus.
Table 2. Intraoperative Parameters
Initial procedure
OP time (mins) Console time (mins)
Warm ischemic 
time (mins)
EBL (mL)
(nephrectomy/
prostatectomy)Nephrectomy Prostatectomy Nephrectomy Prostatectpmy
1  Prostatectomy 136 206 78 110 33 150 (50/150)
2  Prostatectomy 123 144 89 111 24   800 (150/650)
3 Nephrectomy 150 330 103 272 35 700 (50/650)
EBL, estimated blood loss; OP, operation.
Table 3. Postoperative Results
Creatinine 
(mg/dL)
Length of stay 
(days)
Prostate Kidney Morbidity/
motalityGleason score PSM Pathologic stage Pathology/stage
1 1.3   7 0 N    T0N0M0 Clear cell type, grade2/T1 -
2 1.1   7 8 (3+5) N      T2bN0M0 Clear cell type, grade3/T1 -
3 1.4 13 8 (3+5) Y      T4aN0M0 Clear cell type, grade2/T1 Ureteral injury
PSM, positive surgical margin.
Fig. 1. Schematic port placements during prostatectomy (circles) and addi-
tional nephrectomy port (squares). Laparoendoscopic single-site surgery 
(LESS) port strategy. LESS port (bold line) and assistant port for liver traction 
during RAPN (solid circles) reused as a camera port and suction port during 
RALP.
1. LESS port
2-4. Robotic port
5, 6. Assistant port (12 mm)
7. Assistant port 
   (suction and liver 
   traction, 5 mm)
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gle-port due to additional ports for RALP despite of LESS 
technique. We should investigate further port placement 
strategy and special robotic instruments.
Concurrent surgery has many potential benefits because it 
avoids 2 separate procedures. Because patient does not have 
multiple induction of anesthesia, overall hospitalization, 
costs, and the number of port placement are minimized, and 
morbidity associated with anesthesia is reduced.1,2 Despite 
the benefits of concurrent surgery, they have a potential dis-
advantages, including increased total surgical and anesthesia 
time as well as prolonged pneumoperitoneum.1,2 Although 
creatinine levels of all patients were eventually decreased 
within normal range, a postoperative elevation of creatinine 
levels may be related to prolonged pneumoperitoneum. 
However, several studies of laparoscopic complications re-
ported that duration of pneumoperitoneum seems to be a sig-
nificant factor in pulmonary mechanics, but it does not affect 
overall hemodynamic parameters.1,10 In view of the sequence 
of the procedure, performing RALP prior to RLESS PN may 
be reasonable because of vulnerability of home-made single 
port in the process of repositioning of patient. However, sur-
geons need to consider the level of surgical difficulty for 
making an order of priority on concurrent surgery. In the 
present study, we decided to complete RLESS PN first for 
the last case who needed wide excision and extended lymph-
adenectomy.
In our series, patients with large renal tumor and advanced 
prostate cancer were included. RAPN for large renal tumor 
have shown outcomes comparable to smaller tumors, and 
RALP in advanced prostate cancer might have benefits for 
accurate pathological staging, durable local control and long 
term cancer specific survival.11,12 In particular, recent robot 
assisted salvage prostatectomy was performed as alterna-
tive treatment after radiation therapy, similar to the present 
case study.13 However, ureteral injury occurred during wide 
excision to ensure a negative surgical margin in patients 
with advanced prostate cancer (case 3).
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